Current role
Biotechnology · Healthcare
CEO, Board Member
2014-01-01–present
Gerald T. Proehl
Board Member
Dermata Therapeutics, Inc. (DRMA)Equibles does not estimate personal net worth.
Get an email with a short summary when Dermata Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get DRMA alertsAbout Gerald T. Proehl
Gerald T. Proehl is recorded as Board Member at Dermata Therapeutics, Inc. (DRMA) since January 1, 2014 and CEO at Dermata Therapeutics, Inc. (DRMA). The newest filing on record that lists Gerald T. Proehl as CEO and Board Member at Dermata Therapeutics, Inc. (DRMA) is dated April 17, 2026. Dermata Therapeutics, Inc. reported in an 8-K filed May 7, 2024 that Gerald T. Proehl was appointed Class III director, effective May 7, 2024. The proxy statement of Dermata Therapeutics, Inc. reports total compensation of $461,973 for Gerald T. Proehl in fiscal 2024, including a base salary of $280,000. Disclosed compensation is on record for 2 fiscal years. Dermata Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Dermata Therapeutics, Inc. includes Kyri K. Van Hoose (CFO), Kyri Van Hoose (CFO), Andrew Sandler (Board Member) and 7 others.
“The election of Gerald T. Proehl, Wendell Wierenga, Ph.D., and Kathleen Scott as Class III directors to hold office for a term of three years, until their successor is duly elected and qualified or they are otherwise unable to complete their term.”
Affiliation history
-
Current
2014-01-01–present
Last confirmed April 17, 2026
-
Current
Start not stated–present
Last confirmed April 17, 2026
Company network
Leadership on record at Dermata Therapeutics, Inc.
- Kyri K. Van Hoose CFO
- Kyri Van Hoose CFO
- Andrew Sandler Board Member
- Brittany Bradrick Board Member
- David Hale Board Member
- Kathleen Scott Board Member
- Steven Mento Board Member
- Steven Mento, Ph.D. Board Member
- To approve Board Member
- Wendell Wierenga Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Dermata Therapeutics, Inc. (DRMA) | President and Chief Executive Officer | $280,000 | $461,973 |
| 2023 | Dermata Therapeutics, Inc. (DRMA) | President and Chief Executive Officer | $280,000 | $392,000 |